These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 22779687)
1. Proliferative activity and histopathological features in diffuse grade II astrocytomas. Lind-Landström T; Habberstad AH; Torp SH APMIS; 2012 Aug; 120(8):640-7. PubMed ID: 22779687 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of histological features in diffuse astrocytomas WHO grade II. Lind-Landström T; Habberstad AH; Sundstrøm S; Torp SH Int J Clin Exp Pathol; 2012; 5(2):152-8. PubMed ID: 22400076 [TBL] [Abstract][Full Text] [Related]
3. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322 [TBL] [Abstract][Full Text] [Related]
4. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III. Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading]. Takekawa Y; Sawada T; Sakurai I Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
8. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
9. [Malignancy grading of glial tumors. I. Astrocytomas]. Martin H; Schmidt D Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600 [TBL] [Abstract][Full Text] [Related]
14. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas]. Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K Brain Tumor Pathol; 2012 Jul; 29(3):140-7. PubMed ID: 22648019 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. Machen SK; Prayson RA Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840 [TBL] [Abstract][Full Text] [Related]
17. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Gyure KA; Prayson RA Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292 [TBL] [Abstract][Full Text] [Related]